Breaking News Instant updates and real-time market news.

2019-01-09 12:33:19 MDT Medtronic $84.29 1.29 (1.55%) 12:33 01/09/19 01/09 12:33 01/09/19 12:33	Medtronic CFO Parkhill acquires 3,000 shares for $251,610 Medtronic CFO Karen Parkhill disclosed the purchase of 3,000 shares at a price of $83.87 for a total cost of $251,610. Parkhill now owns 83,680 shares of Medtronic.	17 Jan 27 Jan 18 May 28 May
MDT Medtronic $84.29 1.29 (1.55%) 01/02/19 DBAB 01/02/19 INITIATION Target $99 DBAB Buy Medtronic initiated with a Buy at Deutsche Bank Deutsche Bank analyst Pito Chickering started Medtronic with a Buy rating and $99 price target. Deutsche had a Buy rating on the shares under analyst Kristen Stewart before going restricted on the name in June of 2018. 01/04/19 PIPR 01/04/19 NO CHANGE PIPR Piper insulin delivery survey shows Tandem gaining market share Piper Jaffray conducted an insulin delivery survey in November consisting of 140 patients, physicians and certified diabetes educators, analysts led by JP McKim tell investors in a research note. The firm's top three takeaways from the survey are that the introduction of automated insulin delivery systems will increase pump penetration from ~30% today up into the 40%-45% range, Tandem Diabetes (TNDM) is gaining market share from Medtronic (MDT) though both are going to benefit from the Animas exit, and smart pens are more attractive to current multiple daily injection users compared to those already on a pump. Piper keeps Overweight ratings on both Insulet (PODD) and Tandem given this backdrop. It believes near term upside remains the highest for Tandem. 01/07/19 JPMS 01/07/19 NO CHANGE JPMS Overweight Medtronic early view for below trend reported EPS growth in FY20, says JPMorgan JPMorgan analyst Robbie Marcus noted that Medtronic CFO Karen Parkhill discussed expectations for the back half of FY19 and high level views on FY20 at the firm's healthcare conference. For FY19, the company is now expecting organic growth closer to the middle of its 5.0-5.5% range, driven by softness in CVG, said Marcus. The CFO said headwinds from higher tax rates and foreign exchange could push reported EPS growth below the company's long-range target of 8%, but expressed confidence in its ability to still hit its 4% guidance floor, adding that softer reported EPS growth in FY20 should set up FY21 for above trend reported EPS growth, according to Marcus. He maintains an Overweight rating on Medtronic shares, which are down nearly 5% to $83.92 in afternoon trading. 01/08/19 LEHM 01/08/19 NO CHANGE Target $104 LEHM Overweight Medtronic price target lowered to $104 from $113 at Barclays Barclays analyst Kristen Stewart lowered her price target for Medtronic to $104 saying management yesterday made some cautious commentary on the near-term sales outlook and recent tax regulation proposals. It seems that Medtronic "is a bit two steps forward and now one step back," Stewart tells investors in a research note. The analyst, who is not surprised by the 6.5% selloff yesterday, keeps an Overweight rating on the shares, citing valuation and Medtronic's longer term growth prospects with its pipeline.

2019-01-09 12:33:19

MDT

Medtronic

$84.29: 1.29 (1.55%)

12:33

01/09/19

01/09

12:33

01/09/19

12:33

Medtronic CFO Parkhill acquires 3,000 shares for $251,610

Medtronic CFO Karen Parkhill disclosed the purchase of 3,000 shares at a price of $83.87 for a total cost of $251,610. Parkhill now owns 83,680 shares of Medtronic.

17
Jan
27
Jan
18
May
28
May

MDT Medtronic

$84.29: 1.29 (1.55%)

01/02/19: DBAB

01/04/19: PIPR

01/07/19: JPMS

01/08/19: LEHM

TODAY'S FREE FLY STORIES

LOPE Grand Canyon $97.09 0.14 (0.14%) 16:11 02/20/19 02/20 16:11 02/20/19 16:11 Earnings	Grand Canyon sees Q1 EPS $1.49, consensus $1.40 » Sees Q1 revenue $195.5M,… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in in 9 minutes Get Free Trial 03/08/13 Wedge Partners 03/08/13 Credit Suisse 03/06/13 Citigroup 03/06/13 Barclays See Street Research during your Free Trial	20 Feb
MANT ManTech $58.49 0.58 (1.00%) 16:11 02/20/19 02/20 16:11 02/20/19 16:11 Hot Stocks	ManTech increases quarterly dividend to 27c from 25c » The company has increased… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial 03/08/13 Wedge Partners 03/08/13 Credit Suisse 03/06/13 Citigroup 03/06/13 Barclays See Street Research during your Free Trial	20 Feb
ROG Rogers Corporation $136.53 1.23 (0.91%) 16:11 02/20/19 02/20 16:11 02/20/19 16:11 Hot Stocks	Breaking Hot Stocks news story on Rogers Corporation » Rogers Corporation sees… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in in 9 minutes Get Free Trial 03/08/13 Wedge Partners 03/08/13 Credit Suisse 03/06/13 Citigroup 03/06/13 Barclays See Street Research during your Free Trial	20 Feb 07 Mar
XPER Xperi $23.18 0.36 (1.58%) 16:11 02/20/19 02/20 16:11 02/20/19 16:11 Earnings	Breaking Earnings news story on Xperi » Xperi sees Q1 billings… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial 03/08/13 Wedge Partners 03/08/13 Credit Suisse 03/06/13 Citigroup 03/06/13 Barclays See Street Research during your Free Trial	20 Feb 27 Mar 28 Mar
CBLK Carbon Black $16.50 0.16 (0.98%) 16:11 02/20/19 02/20 16:11 02/20/19 16:11 Earnings	Carbon Black sees Q1 EPS (23c)-(22c), consensus (21c) » Sees Q1 revenue… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in in 9 minutes Get Free Trial 03/08/13 Wedge Partners 03/08/13 Credit Suisse 03/06/13 Citigroup 03/06/13 Barclays See Street Research during your Free Trial	20 Feb 25 Feb 04 Mar 05 Mar 13 Mar

ROG Rogers Corporation $136.53 1.23 (0.91%) 16:11 02/20/19 02/20 16:11 02/20/19 16:11 Earnings	Rogers Corporation sees Q1 adjusted EPS $1.25-$1.40, consensus $1.42 » Sees Q1 revenue… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial 03/08/13 Wedge Partners 03/08/13 Credit Suisse 03/06/13 Citigroup 03/06/13 Barclays See Street Research during your Free Trial	20 Feb 07 Mar
XPER Xperi $23.18 0.36 (1.58%) 16:11 02/20/19 02/20 16:11 02/20/19 16:11 Earnings	Breaking Earnings news story on Xperi » Xperi reports Q4 billings… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in in 9 minutes Get Free Trial 03/08/13 Wedge Partners 03/08/13 Credit Suisse 03/06/13 Citigroup 03/06/13 Barclays See Street Research during your Free Trial	20 Feb 27 Mar 28 Mar
AMSWA American Software $11.61 0.09 (0.78%) 16:10 02/20/19 02/20 16:10 02/20/19 16:10 Earnings	American Software reports Q3 adjusted EPS 10c, one estimate 4c » Reports Q3 revenue… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial 03/08/13 Wedge Partners 03/08/13 Credit Suisse 03/06/13 Citigroup 03/06/13 Barclays See Street Research during your Free Trial	20 Feb
ROG Rogers Corporation $136.52 1.22 (0.90%) 16:10 02/20/19 02/20 16:10 02/20/19 16:10 Earnings	Rogers Corporation reports Q4 adjusted EPS $1.67, consensus $1.27 » Reports Q4 revenue… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in in 9 minutes Get Free Trial 03/08/13 Wedge Partners 03/08/13 Credit Suisse 03/06/13 Citigroup 03/06/13 Barclays See Street Research during your Free Trial	20 Feb 07 Mar
CBLK Carbon Black $16.54 0.2 (1.22%) 16:10 02/20/19 02/20 16:10 02/20/19 16:10 Earnings	Carbon Black reports Q4 EPS (20c), consensus (24c) » Reports Q4 revenue… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial 03/08/13 Wedge Partners 03/08/13 Credit Suisse 03/06/13 Citigroup 03/06/13 Barclays See Street Research during your Free Trial	20 Feb 25 Feb 04 Mar 05 Mar 13 Mar

LOPE Grand Canyon $97.03 0.08 (0.08%) 16:10 02/20/19 02/20 16:10 02/20/19 16:10 Earnings	Grand Canyon reports Q4 EPS $1.56, consensus $1.42 » Reports Q4 revenue… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in in 9 minutes Get Free Trial 03/08/13 Wedge Partners 03/08/13 Credit Suisse 03/06/13 Citigroup 03/06/13 Barclays See Street Research during your Free Trial	20 Feb
MANT ManTech $58.49 0.58 (1.00%) 16:10 02/20/19 02/20 16:10 02/20/19 16:10 Earnings	ManTech sees FY19 EPS $2.15-$2.28, consensus $2.32 » Sees FY19 revenue $2.05B… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial 03/08/13 Wedge Partners 03/08/13 Credit Suisse 03/06/13 Citigroup 03/06/13 Barclays See Street Research during your Free Trial	20 Feb
GDDY GoDaddy $72.30 -0.39 (-0.54%) 16:10 02/20/19 02/20 16:10 02/20/19 16:10 Hot Stocks	Breaking Hot Stocks news story on GoDaddy » GoDaddy drops 2% to… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in in 9 minutes Get Free Trial 03/08/13 Wedge Partners 03/08/13 Credit Suisse 03/06/13 Citigroup 03/06/13 Barclays See Street Research during your Free Trial	20 Feb 25 Feb 25 Feb
GDOT Green Dot $74.60 -0.14 (-0.19%) 16:09 02/20/19 02/20 16:09 02/20/19 16:09 Earnings	Green Dot sees FY19 adjusted EPS $3.59-$3.67, consensus $3.62 » Sees FY19 revenue… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial 03/08/13 Wedge Partners 03/08/13 Credit Suisse 03/06/13 Citigroup 03/06/13 Barclays See Street Research during your Free Trial
SITC Site Centers $12.98 -0.41 (-3.06%) 16:09 02/20/19 02/20 16:09 02/20/19 16:09 Earnings	Site Centers sees FY19 FFO $1.13-$1.18, consensus $1.16 » Backs FY19 Same-store NOI… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in in 9 minutes Get Free Trial 03/08/13 Wedge Partners 03/08/13 Credit Suisse 03/06/13 Citigroup 03/06/13 Barclays See Street Research during your Free Trial	20 Feb

A Agilent $78.56 1.08 (1.39%) 16:09 02/20/19 02/20 16:09 02/20/19 16:09 Earnings	Agilent sees Q2 EPS 70c-72c, consensus 72c » Sees Q2 revenue of… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial 03/08/13 Wedge Partners 03/08/13 Credit Suisse 03/06/13 Citigroup 03/06/13 Barclays See Street Research during your Free Trial	20 Feb 27 Feb
GDDY GoDaddy $72.29 -0.4 (-0.55%) 16:09 02/20/19 02/20 16:09 02/20/19 16:09 Earnings	Breaking Earnings news story on GoDaddy » GoDaddy sees Q1 revenue… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in in 9 minutes Get Free Trial 03/08/13 Wedge Partners 03/08/13 Credit Suisse 03/06/13 Citigroup 03/06/13 Barclays See Street Research during your Free Trial	20 Feb 25 Feb 25 Feb
VIPS Vipshop $7.31 0.36 (5.18%) 16:09 02/20/19 02/20 16:09 02/20/19 16:09 Earnings	Vipshop sees Q1 revenue growth 0%-5%, consensus $3.2B » For the first quarter of… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial 03/08/13 Wedge Partners 03/08/13 Credit Suisse 03/06/13 Citigroup 03/06/13 Barclays See Street Research during your Free Trial	21 Feb
GDOT Green Dot $74.68 -0.06 (-0.08%) 16:09 02/20/19 02/20 16:09 02/20/19 16:09 Earnings	Green Dot reports Q4 adjusted EPS 56c, consensus 50c » Reports Q4 revenue… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in in 9 minutes Get Free Trial 03/08/13 Wedge Partners 03/08/13 Credit Suisse 03/06/13 Citigroup 03/06/13 Barclays See Street Research during your Free Trial
MANT ManTech $58.49 0.58 (1.00%) 16:08 02/20/19 02/20 16:08 02/20/19 16:08 Earnings	ManTech reports Q4 EPS 50c, consensus 52c » Reports Q4 revenue… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial 03/08/13 Wedge Partners 03/08/13 Credit Suisse 03/06/13 Citigroup 03/06/13 Barclays See Street Research during your Free Trial	20 Feb

SREV ServiceSource $1.15 -0.03 (-2.54%) 16:08 02/20/19 02/20 16:08 02/20/19 16:08 Earnings	ServiceSource reports Q4 FFO 31c, consensus 30c » Reports Q4 revenue… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in in 9 minutes Get Free Trial 03/08/13 Wedge Partners 03/08/13 Credit Suisse 03/06/13 Citigroup 03/06/13 Barclays See Street Research during your Free Trial	20 Feb 28 Mar
GDDY GoDaddy $72.29 -0.4 (-0.55%) 16:08 02/20/19 02/20 16:08 02/20/19 16:08 Earnings	GoDaddy sees 2019 revenue $2.97B-$3.0B, consensus $2.99B » For the full year 2019,… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial 03/08/13 Wedge Partners 03/08/13 Credit Suisse 03/06/13 Citigroup 03/06/13 Barclays See Street Research during your Free Trial	20 Feb 25 Feb 25 Feb
A Agilent $78.58 1.1 (1.42%) 16:08 02/20/19 02/20 16:08 02/20/19 16:08 Earnings	Agilent raises FY19 EPS view to $3.03-$3.07 from $3.00-$3.05, consensus $3.05 » Raises FY19 revenue view… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in in 9 minutes Get Free Trial 03/08/13 Wedge Partners 03/08/13 Credit Suisse 03/06/13 Citigroup 03/06/13 Barclays See Street Research during your Free Trial	20 Feb 27 Feb
VIPS Vipshop $7.31 0.36 (5.18%) 16:07 02/20/19 02/20 16:07 02/20/19 16:07 Earnings	Vipshop reports Q4 adjusted EPS 19c, consensus 18c » Reports Q4 revenue $3.8B,… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial 03/08/13 Wedge Partners 03/08/13 Credit Suisse 03/06/13 Citigroup 03/06/13 Barclays See Street Research during your Free Trial	21 Feb
NUVA NuVasive $55.59 -1.69 (-2.95%) 16:07 02/20/19 02/20 16:07 02/20/19 16:07 Earnings	NuVasive sees FY19 EPS $2.20-$2.30, consensus $2.47 » Sees FY19 revenue… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial 03/08/13 Wedge Partners 03/08/13 Credit Suisse 03/06/13 Citigroup 03/06/13 Barclays See Street Research during your Free Trial	20 Feb 06 Mar

Events

Earnings calls, analyst events, roadshows and more

CUTR
Today at 16:30

Cutera - CUTR Conference Calls
A
Today at 16:30

Agilent - A Conference Calls
AXTI
Today at 16:30

AXT Inc. - AXTI Conference Calls
LOPE
Today at 16:30

Grand Canyon - LOPE Conference Calls
NUVA
Today at 16:30

NuVasive - NUVA Conference Calls
RBBN
Today at 16:30

Ribbon Communications - RBBN Conference Calls
SEDG
Today at 16:30

SolarEdge - SEDG Conference Calls
EVTC
Today at 16:30

Evertec - EVTC Conference Calls
GHDX
Today at 16:30

Genomic Health - GHDX Conference Calls
SREV
Today at 16:30

ServiceSource - SREV Conference Calls

View All Events »

1 of

Syndicate

This week’s upcoming IPOs and secondary offerings

Priced
Not Priced

Mon	No deals
Tues	AI X AI Arlington Asset Investment Spot Secondary Managers: Morgan Stanley & JMP Securities Priced at: $8.33 6M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial ARR X ARR ARMOUR Residential Spot Secondary Managers: Morgan Stanley & Barclays, Citi, Credit Suisse, Goldman Sachs & JPMorgan Priced at: $20.33 7.2M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial CPT X CPT Camden Property Spot Secondary Managers: BofA/Merrill & Deutsche Bank Priced at: $97.85 3.375M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial NRZ X NRZ New Residential Spot Secondary Managers: Morgan Stanley, Credit Suisse & JPMorgan Priced at: $16.50 40.3M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial OVID X OVID Ovid Therapeutics Spot Secondary Managers: Cowen & William Blair Priced at: $2.00 12.5M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial SNNA X SNNA Sienna Biopharmaceuticals Spot Secondary Managers: Cowen & BMO Capital Priced at: $2.50 8M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial
Wed	No deals
Thurs	No deals
Fri	No deals

Mon	No deals
Tues	No deals
Wed	No deals
Thurs	No deals
Fri	No deals

View All Syndicate Announcements »

Medtronic CFO Parkhill acquires 3,000 shares for $251,610

TODAY'S FREE FLY STORIES

Get Full Fly Access